BusinessAdmera Health Reaches Yet Another Significant Milestone, by Achieving New CLEP Approval for PGxOne™ Plus, a 50 Gene Pharmacogenomics TestBy Nasdaq OMXMar 16, 2017, 2:31 PM UTC